|Last Price||Today's Change||52-Week Range||Trading Volume|
|60.61||-0.21 (-0.35%)||47.55 - 70.54||5.3 million (Below Avg)|
Market data as of 4:03PM 08/28/15. Quotes are delayed by at least 15 min.
FDA Approves U.S. Product Labeling Update for Sprycel® (dasatinib) to Include Five-Year First-Line and Seven-Year Second-Line Efficacy and Safety Data in Chronic Myeloid Leukemia in Chronic Phase
08/13/2015 8:00 AM ET